QRSL1
Basic information
Region (hg38): 6:106629578-106668417
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 40 (Limited), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 40 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 4 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Neurologic | 26741492; 29440775; 30283131 |
ClinVar
This is a list of variants' phenotypes submitted to
- Combined oxidative phosphorylation deficiency 40 (2 variants)
- Cardiomyopathy, mitochondrial (2 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the QRSL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 32 | ||||
missense | 45 | 56 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 2 | 1 | 6 | |
non coding | 20 | 25 | ||||
Total | 2 | 2 | 48 | 37 | 28 |
Highest pathogenic variant AF is 0.0000197
Variants in QRSL1
This is a list of pathogenic ClinVar variants found in the QRSL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-106629627-G-A | Benign (May 14, 2021) | |||
6-106629675-G-A | Benign (May 15, 2021) | |||
6-106629691-C-A | Likely benign (Aug 22, 2022) | |||
6-106629691-C-T | Uncertain significance (Jul 04, 2022) | |||
6-106629697-C-T | Combined oxidative phosphorylation deficiency 40 • Inborn genetic diseases | Uncertain significance (Aug 19, 2023) | ||
6-106629702-A-C | Likely benign (Jan 08, 2024) | |||
6-106629703-G-C | Uncertain significance (Nov 08, 2022) | |||
6-106629722-C-T | Benign (Jan 26, 2024) | |||
6-106629725-T-A | Likely benign (Nov 01, 2023) | |||
6-106640356-C-T | Benign (Jan 29, 2024) | |||
6-106640357-G-A | Likely benign (Mar 02, 2023) | |||
6-106640370-G-A | Inborn genetic diseases | Uncertain significance (Nov 14, 2023) | ||
6-106640399-A-G | Likely benign (May 16, 2022) | |||
6-106640465-G-A | Likely benign (Oct 26, 2023) | |||
6-106640497-G-T | Combined oxidative phosphorylation deficiency 40 | Uncertain significance (Mar 25, 2024) | ||
6-106640501-T-C | Likely benign (Aug 10, 2023) | |||
6-106640505-A-G | Uncertain significance (Feb 09, 2022) | |||
6-106640710-T-A | Benign (May 14, 2021) | |||
6-106640861-G-A | Uncertain significance (Oct 03, 2023) | |||
6-106640862-T-C | Uncertain significance (Aug 22, 2022) | |||
6-106640893-G-A | QRSL1-related disorder | Benign (Jan 18, 2024) | ||
6-106640924-A-G | Uncertain significance (Jul 19, 2022) | |||
6-106641052-TG-T | Benign (May 25, 2021) | |||
6-106642983-A-T | Likely benign (May 30, 2023) | |||
6-106642994-G-A | Inborn genetic diseases | Uncertain significance (Jan 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
QRSL1 | protein_coding | protein_coding | ENST00000369046 | 11 | 38840 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.88e-8 | 0.957 | 125692 | 0 | 56 | 125748 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 228 | 278 | 0.819 | 0.0000134 | 3410 |
Missense in Polyphen | 67 | 109.81 | 0.61014 | 1388 | ||
Synonymous | -0.586 | 111 | 103 | 1.07 | 0.00000519 | 1043 |
Loss of Function | 1.99 | 16 | 27.2 | 0.588 | 0.00000143 | 338 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000474 | 0.000474 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000394 | 0.000392 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu- tRNA(Gln). {ECO:0000255|HAMAP-Rule:MF_03150, ECO:0000269|PubMed:19805282}.;
- Disease
- DISEASE: Note=Defects in QRSL1 may play a role in mitochondrial disorders characterized by combined respiratory chain complex deficiencies. {ECO:0000269|PubMed:26741492}.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);L-glutamine tRNA biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 77.16
Haploinsufficiency Scores
- pHI
- 0.0990
- hipred
- N
- hipred_score
- 0.331
- ghis
- 0.500
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.483
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Qrsl1
- Phenotype
Gene ontology
- Biological process
- regulation of protein stability;mitochondrial translation;glutaminyl-tRNAGln biosynthesis via transamidation
- Cellular component
- mitochondrion;glutamyl-tRNA(Gln) amidotransferase complex
- Molecular function
- amidase activity;protein binding;ATP binding;glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity